Antileishmanial activity against Leishmania infantum MHOM/ES/2007/DP532JFJ infected in mouse BMDM cells assessed as reduction in intracellular amastigotes after 48 hrs
Antileishmanial activity against Leishmania donovani MHOM/IN/00/LEM138 infected in mouse BMDM cells assessed as reduction in intracellular amastigotes after 48 hrs
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as mean survival time at 100 umol/kg, ip administered as single dose
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as cure rate at 100 umol/kg, ip administered as single dose
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as parasite number level ul of blood at 100 umol/kg, ip administered as single dose measured on day 2
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as parasite number level ul of blood at 100 umol/kg, ip administered as single dose measured on day 3
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as parasite number level ul of blood at 100 umol/kg, ip administered as single dose measured on day 4
Antitrypanosomal activity against Trypanosoma brucei brucei CMP infected in Swiss mouse assessed as parasite number level ul of blood at 100 umol/kg, ip administered as single dose measured on day 30
Antileishmanial activity against promastigote stage of Leishmania major assessed as inhibition of parasite proliferation after 48 hrs by Alamar Blue assay